Discovering a Common Goal,
Discovering a Cure

CONTACT  |  DONATE  |  E-NEWSLETTER  | 
  
DRUG NEWS

Research News
Drug News
Conference News
< Home



Biogen and Target ALS Launch $20M Corporate Funding Challenge
February 11, 2016

The Target ALS Foundation has received a $5M donation from Biogen to fund preclinical ALS research across the Foundation’s network of academic laboratories. These funds are the first in the Target ALS...

Add-On Technology Allows Electric Wheelchairs to be Controlled by Thoughts
February 8, 2016

Researchers led by Kiran George at California State University, Fullerton, have developed an affordable ‘mind-controlled’ electric wheelchair by combining a mobile application with a specialized headset that detects brain waves. The...

Biogen Trial Aims to Improve Identification of Most Promising ALS Drug Candidates
February 1, 2016

Objective measures of disease progression have emerged in recent years as perhaps the most important unmet need in the field of ALS clinical trial design. A new study just getting underway aims to propel the field forward, by comparing...

New Initiative ALS ONE Sets Four Year Goal to an ALS Therapy
January 26, 2016

A team of distinguished ALS experts in Massachusetts have joined forces in a new collaborative effort called ALS ONE. ALS ONE strives to accelerate progress towards a therapy for ALS by leveraging the...

Gladstone and Biogen Team Up to Identify Novel Candidate ALS Drugs
January 22, 2016

The biotechnology company Biogen is teaming up with Steven Finkbeiner’s laboratory at the Gladstone Institutes in San Francisco. The goal of the university-industry collaboration is to evaluate promising...





The ALS Forum was developed by Prize4Life, Inc.
 
© 2016 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum